 19 New U.S. and International Patents Issued and Allowed in 2020 REDWOOD CITY, CA ACCESSWIRE January 19, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease PAD, today provided an update on the expansion of its intellectual property portfolio in 2020. Avinger announced the issuance and allowance of 10 new patents in the U.S. and 9 new patents in international markets in 2020, including 7 new patents related to its recently introduced TigereyeTM image-guided CTO crossing catheter. 